Takeda Pharmaceutical Company Limited (TAK)

NYSE: TAK · Real-Time Price · USD

16.41

+0.05 (0.31%)

At close: Apr 28, 2026, 4:00 PM EDT

16.40

-0.01 (-0.06%)

After-hours: Apr 28, 2026, 7:00 PM EDT

Takeda Pharmaceutical Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Takeda Pharmaceutical.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Takeda Pharmaceutical.

Recommendation Trends

Rating	Dec '22	Jan '23	Feb '23	Mar '23	Apr '23
Strong Buy	0	0	0	1	1
Buy	1	1	1	1	1
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	1	1	1	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ken Cacciatore TD Cowen	TD Cowen	Buy Maintains $30 → $20	Buy	Maintains	$30 → $20	+21.88%	May 16, 2023
Ken Cacciatore TD Cowen	TD Cowen	Buy Maintains $24 → $30	Buy	Maintains	$24 → $30	+82.82%	Apr 4, 2023
Koichi Mamegano B of A Securities	B of A Securities	Hold → Strong Buy Upgrades $20	Hold → Strong Buy	Upgrades	$20	+21.88%	Mar 16, 2023
Ken Cacciatore Cowen & Co.	Cowen & Co.	Hold → Buy Upgrades $21 → $24	Hold → Buy	Upgrades	$21 → $24	+46.25%	Jul 19, 2022
Ken Cacciatore Cowen & Co.	Cowen & Co.	Hold Initiates $20	Hold	Initiates	$20	+18.83%	Nov 1, 2019

More Analyst Ratings

Financial Forecast

Revenue This Year

4,588.71B

from 4,581.55B

0.16%

from 4,581.55B

Revenue Next Year

4,644.77B

from 4,588.71B

1.22%

from 4,588.71B

EPS This Year

121.04

from 67.23

80.04%

from 67.23

EPS Next Year

179.71

from 121.04

48.46%

from 121.04

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	3,197.81B	3,569.01B	4,027.48B	4,263.76B	4,581.55B	4,588.71B	4,644.77B
Revenue Growth	-2.84%	11.61%	12.85%	5.87%	7.45%	0.16%	1.22%
EPS	238.96	145.87	201.94	91.16	67.23	121.04	179.71
EPS Growth	745.88%	-38.96%	38.44%	-54.86%	-26.25%	80.04%	48.46%
Forward PE	-	-	-	-	-	21.63	14.57
No. Analysts	-	-	-	-	-	17	17

Financial currency is JPY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	4.8T	5.0T
Avg	4.6T	4.6T
Low	4.4T	4.4T

Revenue Growth

Revenue Growth	2026	2027
High	5.7%	8.6%
Avg	0.2%	1.2%
Low	-3.4%	-4.4%

EPS Forecast

EPS	2026	2027
High	174.83	243.78
Avg	121.04	179.71
Low	96.04	128.18

EPS Growth

EPS Growth	2026	2027
High	160.0%	101.4%
Avg	80.0%	48.5%
Low	42.9%	5.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.